Independent minds. Global perspective. A publication for the builders
Biotechnology / Boston

John Yang.

Founder
Reticular

John Yang co-founded Reticular after AI and mathematics study at MIT and research spanning machine learning and biology. His background also includes a quantitative internship at Goldman Sachs. Reticular's current description concerns genetic prediction, following earlier work on interpreting protein models.

Public-source researchLast checked 1 source ↘
THE STORY, IN CONTEXT

John Yang and the story of Reticular.

Reticular's historical launch presented tools for steering protein AI models and described proof-of-concept work with design partners. The current company description instead emphasizes polygenic prediction for embryo-selection applications and a longer-term disease-research ambition. Yang's research background connects to the broad technical area, but the source does not explain that change in focus. It does not independently establish clinical validity, future cures or the appropriateness of reproductive decisions based on these models.

FROM THE PUBLIC RECORD

Public advice & further reading.

No personal advice is attributed in this profile: a verifiable public advice source has not yet been established. The company and activity facts above remain separately sourced.

Suggest a first-person interview or essay ↗
EVIDENCE IN PLAIN SIGHT

Sources & attribution.

  1. 01
    Reticular — Y Combinator company and active founder profile

    Public active-founder biography, current company status and description, and founding-team launch accounts. Company or team statements are attributed accounts, not independently audited performance results.

    www.ycombinator.com
About this profile

Independently researched from the public sources above. Featured people and companies are not affiliated with BusinessBlogz. Source dates and attribution provide context for the information shown; business claims remain attributed to their original source. Role and company details can change after review. The initials graphic is editorial artwork, not a photograph.

Request a correction or update ↗
KEEP EXPLORING

More builders in Biotechnology.

Explore the sector ↗